Axon Enterprise, Inc. (AXON) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AXON SEC filings page.
Axon Enterprise, Inc. (AXON) reported $3.2B in revenue over the twelve months to Jun 30, 2026, up 34.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling quickly, but heavier operating investment and financing costs are turning growth into thin cash generation.
Revenue rose33.5% in FY2025, yet operating margin turned negative, showing that expansion costs grew faster than gross profit. Because gross margin stayed near59.7% , the deterioration sits below production costs: the model is adding scale while substantially increasing selling, administrative, and development spending.
Cash conversion weakened sharply: operating cash flow was
The balance sheet is simultaneously more liquid and more financing-dependent: current ratio recovered to 2.5x from 1.4x. FY2025 financing activities supplied
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Axon Enterprise, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Axon Enterprise, Inc. has an operating margin of -2.2%, meaning the company loses $2 on every $100 of revenue. This results in a profitability score of 28/100. This is down from 2.8% the prior year.
Axon Enterprise, Inc.'s revenue surged 33.5% year-over-year to $2.8B, reflecting rapid business expansion. This strong growth earns a score of 91/100.
Axon Enterprise, Inc. has elevated debt relative to equity (D/E of 0.53), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 1/100, reflecting increased financial risk.
With a current ratio of 2.53, Axon Enterprise, Inc. holds $2.53 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 71/100.
Axon Enterprise, Inc. has a free cash flow margin of 2.7%, earning a moderate score of 58/100. The company generates positive cash flow after capital investments, but with room for improvement.
Axon Enterprise, Inc. generates a 3.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 26/100. This is down from 16.2% the prior year.
Axon Enterprise, Inc. scores 6.43, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($34.4B) relative to total liabilities ($3.8B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Axon Enterprise, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Axon Enterprise, Inc. generates $1.70 in operating cash flow ($211.3M OCF vs $124.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Axon Enterprise, Inc. reported an operating loss of $62.1M against $94.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Axon Enterprise, Inc. generated $904.4M in revenue in Q2 2026. This represents an increase of 35.3% from the same quarter a year earlier. Against the prior quarter it is up 12.0%.
Axon Enterprise, Inc.'s EBITDA was $79.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 391.5% from the same quarter a year earlier. Against the prior quarter it is up 32.9%.
Axon Enterprise, Inc. reported $29.4M in net income in Q2 2026. This represents a decrease of 18.5% from the same quarter a year earlier. Against the prior quarter it is down 82.6%.
Axon Enterprise, Inc. earned $0.36 per diluted share (EPS) in Q2 2026. This represents a decrease of 18.2% from the same quarter a year earlier. Against the prior quarter it is down 82.4%.
Cash & Balance Sheet
Axon Enterprise, Inc. recorded an outflow of $972K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 99.2% from the same quarter a year earlier. Against the prior quarter it is up 98.2%.
Axon Enterprise, Inc. held $597.7M in cash against $1.7B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Axon Enterprise, Inc.'s gross margin was 60.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.
Axon Enterprise, Inc.'s operating margin was 5.2% in Q2 2026, reflecting core business profitability. This is up 5.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.
Axon Enterprise, Inc.'s net profit margin was 3.3% in Q2 2026, showing the share of revenue converted to profit. This is down 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 17.7 percentage points.
Axon Enterprise, Inc.'s ROE was 0.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.0 percentage points.
Capital Allocation
Axon Enterprise, Inc. invested $208.7M in research and development in Q2 2026. This represents an increase of 28.4% from the same quarter a year earlier. Against the prior quarter it is up 10.4%.
Axon Enterprise, Inc. invested $21.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 8.3% from the same quarter a year earlier. Against the prior quarter it is down 9.0%.
Not reported for Q2 2026.
AXON Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $904.4M+35.3% | $807.3M+33.7% | $796.7M+38.5% | $710.6M+30.6% | $668.5M+32.8% | $603.6M+31.3% | $575.1M+33.6% | $544.3M+31.7% |
| Cost of Revenue | $357.9M+35.2% | $330.1M+38.7% | $335.4M+46.3% | $283.3M+32.7% | $264.8M+34.4% | $237.9M+18.2% | $229.3M+37.8% | $213.5M+36.3% |
| Gross Profit | $546.4M+35.3% | $477.3M+30.5% | $461.3M+33.4% | $427.3M+29.2% | $403.7M+31.9% | $365.7M+41.4% | $345.8M+31.0% | $330.7M+28.9% |
| R&D Expenses | $208.7M+28.4% | $188.9M+25.1% | $194.0M+44.2% | $176.7M+54.3% | $162.6M+60.3% | $151.0M+65.8% | $134.6M | $114.5M+48.9% |
| SG&A Expenses | $291.0M+20.1% | $259.1M+15.9% | $317.4M+39.8% | $252.8M+31.5% | $242.2M+41.7% | $223.5M+47.9% | $227.0M+65.4% | $192.2M+57.1% |
| Operating Income | $46.8M+4615.3% | $29.2M+432.6% | -$50.1M-218.1% | -$2.1M-108.8% | -$1.0M-103.1% | -$8.8M-153.4% | -$15.8M-136.9% | $24.1M-58.1% |
| EBITDA | $79.2M+391.5% | $59.6M+459.1% | -$23.2M-1303.8% | $17.5M-52.9% | $16.1M-63.5% | $10.7M-55.2% | $1.9M-96.1% | $37.1M-33.9% |
| Interest Expense | $28.1M-2.0% | $28.6M+266.2% | $28.8M+1479.1% | $28.9M+1656.5% | $28.7M+1433.2% | $7.8M+345.4% | $1.8M | $1.6M |
| Income Tax | $3.3M+104.3% | $30.9M+51.4% | -$69.0M-36.3% | $17.9M+42.6% | -$75.0M-849.9% | $20.4M-37.3% | -$50.6M-3731.9% | $12.5M+20.4% |
| Net Income | $29.4M-18.5% | $169.3M+92.4% | $2.7M-98.0% | -$2.2M-103.3% | $36.1M-12.9% | $88.0M-34.0% | $135.2M+136.9% | $67.0M+9.3% |
| EPS (Basic) | $0.37-19.6% | $2.11+85.1% | $0.03-98.3% | -$0.03-103.4% | $0.46-16.4% | $1.14-35.6% | $1.78+134.2% | $0.89+8.5% |
| EPS (Diluted) | $0.36-18.2% | $2.05+89.8% | $0.03-98.2% | -$0.03-103.5% | $0.44-17.0% | $1.08-37.6% | $1.68+124.0% | $0.86+6.2% |
| Diluted Shares (Avg) | 83M+0.6% | 82M+1.2% | N/A | 78M+0.4% | 82M+5.8% | 81M+5.6% | N/A | 78M+2.8% |
AXON Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.5B+20.4% | $7.1B+16.2% | $7.0B+56.4% | $6.7B+66.2% | $6.2B+66.1% | $6.1B+69.7% | $4.5B+31.3% | $4.0B+23.1% |
| Current Assets | $3.0B-21.5% | $2.7B-27.3% | $3.7B+61.6% | $4.2B+73.3% | $3.8B+73.6% | $3.8B+71.6% | $2.3B-4.0% | $2.4B+7.8% |
| Cash & Equivalents | $597.7M-2.9% | $458.9M-58.0% | $1.2B+164.1% | $1.4B+104.8% | $615.5M+8.7% | $1.1B+170.6% | $454.8M-24.0% | $695.1M+71.2% |
| Short-Term Investments | $75.7M-94.9% | $260.0M-76.3% | $505.4M+51.7% | $952.8M+205.8% | $1.5B+265.6% | $1.1B+96.2% | $333.2M-48.3% | $311.6M-56.5% |
| Inventory | $486.6M+57.7% | $408.0M+45.9% | $341.8M+28.8% | $317.5M+16.6% | $308.5M+11.1% | $279.7M+3.1% | $265.3M-1.7% | $272.3M+4.7% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.9B+149.1% | $1.9B+150.6% | $1.4B+81.0% | $773.4M+150.7% | $762.2M+147.7% | $755.9M+145.0% | $756.8M+1206.1% | $308.5M+437.9% |
| Total Liabilities | $3.8B+9.3% | $3.5B+0.2% | $3.8B+75.0% | $3.6B+90.4% | $3.5B+92.0% | $3.5B+100.0% | $2.1B+19.7% | $1.9B+10.0% |
| Current Liabilities | $1.4B+7.8% | $1.2B-9.6% | $1.5B-12.4% | $1.3B-10.2% | $1.3B+69.3% | $1.3B-4.3% | $1.7B+120.3% | $1.5B+109.3% |
| Non-Current Liabilities | $2.4B+10.2% | $2.3B+6.1% | $2.3B+387.7% | $2.3B+465.6% | $2.2B+108.7% | $2.2B+498.0% | $469.0M-54.5% | $403.1M-60.3% |
| Long-Term Debt | $1.7B+0.2% | $1.7B+0.2% | $1.7B | $1.7B | $1.7B | $1.7B | $0-100.0% | N/A |
| Total Equity | $3.7B+34.5% | $3.5B+38.3% | $3.2B+39.3% | $3.0B+44.2% | $2.7B+41.3% | $2.6B+40.3% | $2.3B+44.1% | $2.1B+37.7% |
| Retained Earnings | $1.1B+21.3% | $1.1B+22.9% | $936.7M+15.4% | $933.9M+38.0% | $936.1M+54.7% | $900.0M+58.4% | $812.0M+86.7% | $676.8M+81.0% |
Not reported in any period shown, so not listed: Accounts Receivable.
AXON Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $20.1M+121.9% | -$31.5M-222.2% | $217.2M-13.2% | $60.0M-34.3% | -$91.7M-210.8% | $25.8M+261.8% | $250.2M+78.6% | $91.3M+45.2% |
| Depreciation & Amortization | $32.5M+89.2% | $30.4M+56.1% | $26.9M+52.4% | $19.6M+50.8% | $17.2M+65.2% | $19.5M+164.5% | $17.7M+173.2% | $13.0M+1081.4% |
| Stock-Based Compensation | $144.0M+3.4% | $134.7M-3.9% | N/A | $146.2M+43.6% | $139.2M+86.1% | $140.2M+86.7% | N/A | $101.8M+239.4% |
| Capital Expenditures | $21.0M-8.3% | $23.1M-7.0% | $61.8M+149.2% | $26.6M+0.6% | $23.0M+102.8% | $24.9M+53.5% | $24.8M+3.3% | $26.5M+89.4% |
| Free Cash Flow | -$972K+99.2% | -$54.6M-5962.9% | $155.4M-31.0% | $33.4M-48.5% | -$114.7M-260.5% | $932K+102.9% | $225.4M+94.2% | $64.8M+32.6% |
| Investing Cash Flow | $151.2M+139.1% | -$616.9M+12.1% | -$226.4M+48.7% | $590.3M+1270.4% | -$386.5M-570.6% | -$702.2M-303.5% | -$441.7M-930.8% | $43.1M+135.3% |
| Financing Cash Flow | -$30.3M-594.8% | -$92.3M-107.0% | -$215.6M-556.6% | $159.2M+2163.6% | -$4.4M-99.8% | $1.3B+48558.5% | -$32.8M-759.8% | -$7.7M-8.3% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AXON Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.4%0.0pp | 59.1%-1.5pp | 57.9%-2.2pp | 60.1%-0.6pp | 60.4%-0.5pp | 60.6%+4.3pp | 60.1%-1.2pp | 60.8%-1.3pp |
| Operating Margin | 5.2%+5.3pp | 3.6%+5.1pp | -6.3%-3.5pp | -0.3%-4.7pp | -0.1%-6.9pp | -1.5%-5.0pp | -2.7%-12.7pp | 4.4%-9.5pp |
| Net Margin | 3.3%-2.1pp | 21.0%+6.4pp | 0.3%-23.2pp | -0.3%-12.6pp | 5.4%-2.8pp | 14.6%-14.4pp | 23.5%+10.2pp | 12.3%-2.5pp |
| Return on Equity | 0.8%-0.5pp | 4.8%+1.3pp | 0.1%-5.7pp | -0.1%-3.3pp | 1.3%-0.8pp | 3.4%-3.9pp | 5.8%+2.3pp | 3.2%-0.8pp |
| Return on Assets | 0.4%-0.2pp | 2.4%+0.9pp | 0.0%-3.0pp | 0.0%-1.7pp | 0.6%-0.5pp | 1.5%-2.3pp | 3.0%+1.4pp | 1.7%-0.2pp |
| Current Ratio | 2.15-0.8x | 2.27-0.6x | 2.53+1.2x | 3.12+1.5x | 2.95+0.1x | 2.83+1.3x | 1.37-1.8x | 1.62-1.5x |
| Debt-to-Equity | 0.47-0.2x | 0.49-0.2x | 0.53+0.5x | 0.57-0.3x | 0.63-0.3x | 0.68-0.3x | 0.00-0.4x | 0.91-0.2x |
| Asset Turnover | 0.120.0x | 0.110.0x | 0.110.0x | 0.110.0x | 0.110.0x | 0.100.0x | 0.130.0x | 0.140.0x |
| FCF Margin | -0.1%+17.0pp | -6.8%-6.9pp | 19.5%-19.7pp | 4.7%-7.2pp | -17.2%-31.4pp | 0.1%+7.1pp | 39.2%+12.2pp | 11.9%+0.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Axon Enterprise, Inc. AXON | FY2025 | $2.8B | $124.7M | 4.5% | $34.4B | 46/100 |
| L3Harris Technologies, Inc. LHX | FY2026 | N/A | $1.6B | N/A | $44.1B | — |
| Howmet Aerospace Inc. HWM | FY2025 | $8.3B | $1.5B | 18.3% | $88.8B | 71/100 |
| TransDigm Group Incorporated TDG | FY2025 | $8.8B | $2.1B | 23.5% | $60.2B | 73/100 |
| Northrop Grumman Corp. NOC | FY2025 | $42.0B | $4.2B | 10.0% | $68.8B | 49/100 |
| General Dynamics Corporation GD | FY2025 | $52.5B | $4.2B | 8.0% | $89.3B | 63/100 |
Where Axon Enterprise, Inc. Ranks
Frequently Asked Questions
What is Axon Enterprise, Inc.'s annual revenue?
Axon Enterprise, Inc. (AXON) reported $2.8B in total revenue for fiscal year 2025. This represents a 33.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Axon Enterprise, Inc.'s revenue growing?
Axon Enterprise, Inc. (AXON) revenue grew by 33.5% year-over-year, from $2.1B to $2.8B in fiscal year 2025.
Is Axon Enterprise, Inc. profitable?
Yes, Axon Enterprise, Inc. (AXON) reported a net income of $124.7M in fiscal year 2025, with a net profit margin of 4.5%.
What is Axon Enterprise, Inc.'s EBITDA?
Axon Enterprise, Inc. (AXON) had EBITDA of $21.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Axon Enterprise, Inc. have?
As of fiscal year 2025, Axon Enterprise, Inc. (AXON) had $1.2B in cash and equivalents against $1.7B in long-term debt.
What is Axon Enterprise, Inc.'s gross margin?
Axon Enterprise, Inc. (AXON) had a gross margin of 59.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Axon Enterprise, Inc.'s operating margin?
Axon Enterprise, Inc. (AXON) had an operating margin of -2.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Axon Enterprise, Inc.'s net profit margin?
Axon Enterprise, Inc. (AXON) had a net profit margin of 4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Axon Enterprise, Inc.'s return on equity (ROE)?
Axon Enterprise, Inc. (AXON) has a return on equity of 3.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Axon Enterprise, Inc.'s free cash flow?
Axon Enterprise, Inc. (AXON) generated $75.1M in free cash flow during fiscal year 2025. This represents a -77.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Axon Enterprise, Inc.'s operating cash flow?
Axon Enterprise, Inc. (AXON) generated $211.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Axon Enterprise, Inc.'s total assets?
Axon Enterprise, Inc. (AXON) had $7.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Axon Enterprise, Inc.'s capital expenditures?
Axon Enterprise, Inc. (AXON) invested $136.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Axon Enterprise, Inc. spend on research and development?
Axon Enterprise, Inc. (AXON) invested $684.3M in research and development during fiscal year 2025.
What is Axon Enterprise, Inc.'s current ratio?
Axon Enterprise, Inc. (AXON) had a current ratio of 2.53 as of fiscal year 2025, which is generally considered healthy.
What is Axon Enterprise, Inc.'s debt-to-equity ratio?
Axon Enterprise, Inc. (AXON) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Axon Enterprise, Inc.'s return on assets (ROA)?
Axon Enterprise, Inc. (AXON) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Axon Enterprise, Inc.'s P/E ratio?
Axon Enterprise, Inc. (AXON) trades at 172x earnings, its market capitalization divided by net income of $199.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $34.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Axon Enterprise, Inc.'s price-to-sales ratio?
Axon Enterprise, Inc. (AXON) trades at 10.7x sales, its market capitalization divided by revenue of $3.2B revenue, trailing 12 months to June 30, 2026. The market capitalization is $34.4B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Axon Enterprise, Inc.'s Altman Z-Score?
Axon Enterprise, Inc. (AXON) has an Altman Z-Score of 6.43, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Axon Enterprise, Inc.'s Piotroski F-Score?
Axon Enterprise, Inc. (AXON) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Axon Enterprise, Inc.'s earnings high quality?
Axon Enterprise, Inc. (AXON) has an earnings quality ratio of 1.70x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Axon Enterprise, Inc. cover its interest payments?
Axon Enterprise, Inc. (AXON) reported an operating loss of $62.1M against $94.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Axon Enterprise, Inc.?
Axon Enterprise, Inc. (AXON) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.